1 – 27 of 27
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Ophthalmic manifestations in children with tuberous sclerosis complex
(
- Contribution to journal › Article
-
Mark
The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden – data from the Swedish Macula Register
(
- Contribution to journal › Article
-
Mark
The prevalence of visual axis opacification in the Swedish Pediatric Cataract Register
2024) In Acta Ophthalmologica(
- Contribution to journal › Article
-
Mark
Maculopathy and adult-onset ataxia in patients with biallelic MFSD8 variants
(
- Contribution to journal › Article
- 2023
-
Mark
Co-occurrence of CLCN2-related leukoencephalopathy and SPG56
(
- Contribution to journal › Article
-
Mark
Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosis
(
- Contribution to journal › Article
-
Mark
A Description of the Yield of Genetic Reinvestigation in Patients with Inherited Retinal Dystrophies and Previous Inconclusive Genetic Testing
(
- Contribution to journal › Article
- 2022
-
Mark
A five-year follow-up of ABCA4 carriers showing deterioration of retinal function and increased structural changes
(
- Contribution to journal › Article
-
Mark
Abnormal Appearance of the Area Centralis in Labrador Retrievers With an ABCA4 Loss-of-function Mutation
(
- Contribution to journal › Article
-
Mark
Electrophysiological evaluation and 18-month follow-up of two regimens with aflibercept for neovascular age-related macular degeneration
(
- Contribution to journal › Article
-
Mark
A novel phenotype associated with the R162W variant in the KCNJ13 gene
(
- Contribution to journal › Article
- 2021
-
Mark
Autosomal recessive Stickler syndrome associated with homozygous mutations in the COL9A2 gene
(
- Contribution to journal › Article
- 2019
-
Mark
Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?
(
- Contribution to journal › Letter
- 2018
-
Mark
Full-field ERG as a predictor of the natural course of ABCA4-associated retinal degenerations
(
- Contribution to journal › Article
- 2017
-
Mark
An Expanded Multi-Organ Disease Phenotype Associated with Mutations in YARS
(
- Contribution to journal › Article
-
Mark
Ataxia-pancytopenia syndrome with SAMD9L mutations
(
- Contribution to journal › Article
- 2016
-
Mark
Characterization of macular structure and function in two swedish families with genetically identified autosomal dominant retinitis pigmentosa
(
- Contribution to journal › Article
-
Mark
Increased Plasma cGMP in a Family With Autosomal Recessive Retinitis Pigmentosa Due to Homozygous Mutations in the PDE6A Gene
(
- Contribution to journal › Article
-
Mark
Mutations in CEP78 Cause Cone-Rod Dystrophy and Hearing Loss Associated with Primary-Cilia Defects
(
- Contribution to journal › Article
- 2015
-
Mark
Reduced macular function in ABCA4 carriers.
(
- Contribution to journal › Article
- 2014
-
Mark
Association between genotype and phenotype in families with mutations in the ABCA4 gene.
(
- Contribution to journal › Article
-
Mark
Attenuation of the retinal nerve fibre layer and reduced retinal function assessed by optical coherence tomography and full-field electroretinography in patients exposed to vigabatrin medication.
(
- Contribution to journal › Article
- 2011
-
Mark
Electrophysiological evaluation of retinal function in children receiving vigabatrin medication
(
- Contribution to journal › Article
- 2010
-
Mark
Ocular function and morphology in humans and rabbits exposed to vigabatrin medication
(
- Thesis › Doctoral thesis (compilation)
- 2009
-
Mark
Dose-related changes in retinal function and PKC-alpha expression in rabbits on vigabatrin medication : Effect of vigabatrin in the rabbit eye.
(
- Contribution to journal › Article
- 2008
-
Mark
Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy.
(
- Contribution to journal › Article
- 2006
-
Mark
Retinal function in rabbits does not improve 4-5 months after terminating treatment with vigabatrin.
(
- Contribution to journal › Article